HIGHLIGHTS
- who: Yunfei Bai et al. from the The University of Manchester, United Kingdom have published the research: Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody, in the Journal: (JOURNAL)
- what: The authors report the presence of ARAs in a male patient with anti-NF155 antibodies who Frontiers in Immunology
- future: And the authors also believe that the new humanized anti-CD20 monoclonal antibody might serve as a promising therapeutic alternative in anti-NF155 nodopathy but further studies are needed to confirm this in the future. Research is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.